McKinley Carter Wealth Services Inc. Has $1.08 Million Holdings in Johnson & Johnson (JNJ)

McKinley Carter Wealth Services Inc. boosted its holdings in Johnson & Johnson (NYSE:JNJ) by 14.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,308 shares of the company’s stock after purchasing an additional 1,052 shares during the quarter. McKinley Carter Wealth Services Inc.’s holdings in Johnson & Johnson were worth $1,080,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Lenox Wealth Advisors Inc. raised its position in shares of Johnson & Johnson by 0.6% in the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Landmark Financial Advisors LLC raised its position in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Landmark Financial Advisors LLC now owns 1,962 shares of the company’s stock valued at $259,000 after buying an additional 7 shares in the last quarter. Paradigm Financial Advisors LLC raised its position in shares of Johnson & Johnson by 0.3% in the 2nd quarter. Paradigm Financial Advisors LLC now owns 2,649 shares of the company’s stock valued at $350,000 after buying an additional 9 shares in the last quarter. Premier Asset Management LLC raised its position in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Premier Asset Management LLC now owns 2,749 shares of the company’s stock valued at $363,000 after buying an additional 12 shares in the last quarter. Finally, Lbmc Investment Advisors LLC raised its position in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Lbmc Investment Advisors LLC now owns 3,718 shares of the company’s stock valued at $492,000 after buying an additional 14 shares in the last quarter. Institutional investors and hedge funds own 65.71% of the company’s stock.

Shares of Johnson & Johnson (NYSE:JNJ) opened at $147.36 on Friday. Johnson & Johnson has a 1-year low of $110.76 and a 1-year high of $148.32. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The firm has a market cap of $395,885.59, a P/E ratio of 20.64, a price-to-earnings-growth ratio of 2.76 and a beta of 0.80.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s payout ratio is 58.33%.

JNJ has been the subject of several analyst reports. Credit Suisse Group set a $154.00 target price on shares of Johnson & Johnson and gave the company an “outperform” rating in a research report on Thursday, October 19th. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $147.40 target price for the company in a research report on Monday, January 1st. Royal Bank of Canada boosted their target price on shares of Johnson & Johnson from $144.00 to $147.00 and gave the company an “outperform” rating in a research report on Wednesday, October 18th. Citigroup initiated coverage on shares of Johnson & Johnson in a research report on Monday, September 25th. They issued a “neutral” rating and a $140.00 target price for the company. Finally, Jefferies Group upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and boosted their target price for the company from $145.00 to $157.00 in a research report on Wednesday, October 11th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $145.94.

TRADEMARK VIOLATION WARNING: This piece of content was reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.truebluetribune.com/2018/01/21/mckinley-carter-wealth-services-inc-has-1-08-million-holdings-in-johnson-johnson-jnj.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply